Literature DB >> 2956889

Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats.

N Makino, K S Dhalla, V Elimban, N S Dhalla.   

Abstract

Heart sarcolemmal membranes were isolated by the sucrose density gradient method from rats with chronic diabetes induced by a streptozotocin (65 mg/kg iv) injection. Na+-dependent Ca2+-uptake activities were significantly depressed in diabetic sarcolemmal membranes; such alterations were evident at different incubation times and at different concentrations of Ca2+. Administration of insulin to diabetic rats normalized the Na+-dependent Ca2+-uptake activities. ATP-dependent Ca2+ accumulation and Ca2+-stimulated Mg2+-dependent ATPase, which represents Ca2+-pump mechanisms, were significantly depressed in sarcolemmal preparations for diabetic rats and these changes were also reversible upon insulin treatment. An increase in lysophosphatidylcholine and a decrease in phosphatidylethanolamine as well as diphosphatidylglycerol contents were observed in heart membranes isolated from diabetic rats but other phospholipids were unchanged. Cholesterol-to-phospholipid ratio was significantly increased in preparations from diabetic rats. These results indicate a depression in the ability of the cell to remove Ca2+ through Na+-Ca2+ exchange and Ca2+-pump mechanisms in sarcolemma, and these defects may contribute to the occurrence of intracellular Ca2+ overload and diabetic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956889     DOI: 10.1152/ajpendo.1987.253.2.E202

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  42 in total

1.  Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy.

Authors:  N Kaul; N Siveski-Iliskovic; M Hill; N Khaper; C Seneviratne; P K Singal
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Insulin effects on cardiac Na+/Ca2+ exchanger activity: role of the cytoplasmic regulatory loop.

Authors:  María Celeste Villa-Abrille; Agnieszka Sidor; Brian O'Rourke
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

Review 3.  Regulation of cardiolipin biosynthesis in the heart.

Authors:  G M Hatch
Journal:  Mol Cell Biochem       Date:  1996-06-21       Impact factor: 3.396

Review 4.  Mechanisms of subcellular remodeling in heart failure due to diabetes.

Authors:  Naranjan S Dhalla; Nobuakira Takeda; Delfin Rodriguez-Leyva; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 5.  Cardiomyopathy associated with noninsulin-dependent diabetes.

Authors:  S W Schaffer
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

6.  Influence of calcium channel blocker treatment on the mechanical properties of diabetic rat myocardium.

Authors:  R A Brown; M M Lee; A M Sundareson; D J Woodbury; A O Savage
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

7.  Modulation of Na+-Ca2+ exchange in cardiac sarcolemmal vesicles by Ca2+ antagonists.

Authors:  T Hata; N Makino; H Nakanishi; T Yanaga
Journal:  Mol Cell Biochem       Date:  1988-11       Impact factor: 3.396

8.  Decrease in cardiac phosphatidylglycerol in streptozotocin-induced diabetic rats does not affect cardiolipin biosynthesis: evidence for distinct pools of phosphatidylglycerol in the heart.

Authors:  G M Hatch; S G Cao; A Angel
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

9.  Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.

Authors:  L Golfman; I M Dixon; N Takeda; A Lukas; K Dakshinamurti; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

10.  Effect of metoprolol on activity of beta-adrenoceptor coupled to guanine nucleotide binding regulatory proteins in adriamycin-induced cardiotoxicity.

Authors:  L X Fu; C H Bergh; J Hoebeke; Q M Liang; K G Sjögren; F Waagstein; A Hjalmarson
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.